TENX
Tenax Therapeutics, Inc.
14.96
3 x 14.86
1 x 14.96
bid
ask
+
1.67
12.53%
10:16 AM
timesize
| Ytd | 22.68% | |
| 1y | 160.54% |
14.00
day range
15.40
5.68
52 week range
18.38
| Open | 14.66 | Prev Close | 13.29 | Low | 14.00 | High | 15.40 | Mkt Cap | 395.49M |
| Vol | 1.22M | Avg Vol | 819.54K | EPS | -1.41 | P/E | N/A | Forward P/E | -1.06 |
| Beta | 2.15 | Short Ratio | 1.46 | Inst. Own | 47.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 12.30 | 200-d Avg | 11.34 | 1yr Est | 16.30 |
| Income Statement | |||
| Operating Expenses | 16.57M | ||
| Research and Development Expense | 11.54M | ||
| Selling, General and Administrative Expense | 5.03M | ||
| Operating Income | -16.57M | ||
| Net Income | -15.72M | ||
| Net Income Common Stock | -15.72M | ||
| Net Income Common Stock (USD) | -15.72M | ||
| Consolidated Income | -15.72M | ||
| Earnings per Basic Share | -0.35 | ||
| Earnings per Basic Share (USD) | -0.35 | ||
| Earnings per Diluted Share | -0.35 | ||
| Earning Before Interest & Taxes (EBIT) | -15.72M | ||
| Earning Before Interest & Taxes (USD) | -15.72M | ||
| Weighted Average Shares | 45.23M | ||
| Weighted Average Shares Diluted | 45.23M | ||
| Balance Sheet | |||
| Cash and Equivalents | 118.76M | ||
| Cash and Equivalents (USD) | 118.76M | ||
| Current Assets | 123.18M | ||
| Total Assets | 123.18M | ||
| Current Liabilities | 8.49M | ||
| Total Liabilities | 8.49M | ||
| Accumulated Retained Earnings (Deficit) | -383.17M | ||
| Shareholders Equity | 114.69M | ||
| Shareholders Equity (USD) | 114.69M | ||
| Trade and Non-Trade Payables | 6.35M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 30.50M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 21.19M | ||
| Issuance (Purchase) of Equity Shares | 30.50M | ||
| Net Cash Flow from Operations | -9.31M | ||
| Share Based Compensation | 2.84M | ||